Erratum to: Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: A two-arm, randomised clinical trial (Journal of Cancer Research and Clinical Oncology (2014) 140, (211-219) DOI: 10.1007/s00432-013-1568-0);Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: A two-arm, randomised clinical trial

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 2, 2014, Pages 211-219

  Yang, Minjie ^a   Fang, Zhuting ^a,b   Yan, Zhiping ^a   Luo, Jianjun ^a   Liu, Lingxiao ^a   Zhang, Wen ^a   Wu, Linlin ^a   Ma, Jingqin ^a   Yang, Qinghui ^a   Liu, Qingxin ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Brachytherapy; Hepatocellular carcinoma; Iodine 125 seed; Portal vein thrombosis

Indexed keywords

DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; IODINE 125; RADIOACTIVE SEED;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED EMESIS; CHIBA NEEDLE; CHILD PUGH SCORE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; ENDOVASCULAR IMPLANTATION; FEASIBILITY STUDY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SAFETY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR THROMBUS; UPPER ABDOMINAL PAIN;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTAL VEIN; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VENOUS THROMBOSIS;

EID: 84895075092     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1599-1     Document Type: Erratum

References (27)

1. Boettcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA (1994) Endovascular irradiation - a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 29(1):183-186
2. Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020-1022. doi: 10.1002/hep.24199
3. Chen Y, Wang XL, Yan ZP, Wang JH, Cheng JM, Gong GQ, Luo JJ (2012) The use of (1)(2)(5)I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biotherapy Radiopharm 27(5):317-323. doi: 10.1089/cbr 2011.0999
4. Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, Khorana AA (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res 122(3):299-306. doi: 10.1016/j.thromres.2007.10.009
5. Guo JH, Teng GJ, Zhu GY, He SC, Fang W, Deng G, Li GZ (2008) Self-expandable esophageal stent loaded with I-125 seeds: initial experience in patients with advanced esophageal cancer. Radiology 247(2):574-581. doi: 10.1148/radiol.2472070999
6. Higaki I, Hirohashi K, Kubo S, Tanaka H, Tsukamoto T, Omura T, Kinoshita H (2000) Portal vein stenting to treat portal vein tumour thrombus in hepatocellular carcinoma. Osaka City Med J 46(2):99-104
7. Ii N, Yamakado K, Shouji K, Nomoto Y, Nakatsuka A, Nomura M, Yamashita Y, Takaki H, Akeboshi M, Senga M, Shiraki K, Takeda K (2007) Multimodality therapy using brachytherapy for caval tumour of hepatocellular carcinoma. Hepatogastroenterology 54(77):1522-1525
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90. doi: 10.3322/caac.20107
9. Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, Kho KC, Kim TH, Ahn YC, Huh SJ (2005) Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 103(11):2419-2426. doi: 10.1002/cncr.21043
10. Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr, Gates VL, Abecassis M, Omary RA, Salem R (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47(1):71-81. doi: 10.1002/hep.21980
11. Lai YC, Shih CY, Jeng CM, Yang SS, Hu JT, Sung YC, Liu HT, Hou SM, Wu CH, Chen TK (2003) Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumour thrombosis. World J Gastroenterol WJG 9(12):2666-2670
12. Lau WY, Ho S, Leung TWT, Chan M, Ho R, Johnson PJ, Li AKC (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of (90) yttrium microspheres. Int J Radiat Oncol Biol Phys 40(3):583-592. doi: 10.1016/s0360-3016(97)00818-3
13. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52-60. doi: 10.1055/s-0030- 1247132
14. Liu MT, Li SH, Chu TC, Hsieh CY, Wang AY, Chang TH, Pi CP, Huang CC, Lin JP (2004) Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolisation. Jpn J Clin Oncol 34(9):532-539. doi: 10.1093/jjco/hyh089
15. Llado L, Virgili J, Figueras J, Valls C, Dominguez J, Rafecas A, Torras J, Fabregat J, Guardiola J, Jaurrieta E (2000) A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolisation. Cancer 88(1):50-57
16. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, Group SIS (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378-390. doi: 10.1056/NEJMoa0708857
17. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Bru C, Rodes J, Bruix J (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29(1):62-67. doi: 10.1002/hep.510290145
18. Luo J, Yan Z, Liu Q, Qu X, Wang J (2011) Endovascular placement of iodine-125 seed strand and stent combined with chemoembolisation for treatment of hepatocellular carcinoma with tumour thrombus in main portal vein. J Vasc Interv Radiol 22(4):479-489. doi: 10.1016/j.jvir.2010.11.029
19. Morris WJ, Keyes M, Palma D, Spadinger I, McKenzie MR, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Berthelet E, Pai H (2009) Population-based study of biochemical and survival outcomes after permanent I-125 brachytherapy for low- and intermediate-risk prostate cancer. Urology 73(4):860-865. doi: 10.1016/j.urology.2008.07.064
20. National Cancer Institution (2009) Common terminology criteria for adverse events (CTCAE) vesion 4.0
21. Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs AK (2008) TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther 8(10):1623-1641. doi: 10.1586/14737140.8.10.1623
22. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney A (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15(4):335-345
23. Yamada K, Izaki K, Sugimoto K, Mayahara H, Morita Y, Yoden E, Matsumoto S, Soejima T, Sugimura K (2003) Prospective trial of combined transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for portal vein tumour thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57(1):113-119
24. Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K (1999) Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol 30(4):660-668. doi: 10.1016/s0168-8278(99)80197-4
25. Zhang XB, Wang JH, Yan ZP, Qian S, Du SS, Zeng ZC (2009) Hepatocellular carcinoma with main portal vein tumour thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolisation. Cancer 115(6):1245-1252. doi: 10.1002/cncr.24139
26. Zhang W, Yan ZP, Luo JJ, Fang ZT, Wu LL, Liu QX, Qu XD, Liu LX, Wang JH (2013) Iodine-125 Seeds strand for treatment of tumour thrombus in inferior vena cava: an experimental study in a rabbit model. Cardiovasc Intervent Radiol 36(5):1371-1382. doi: 10.1007/s00270-013-0628-9
27. Zhu HD, Guo JH, Zhu GY, He SC, Fang W, Deng G, Qin YL, Li GZ, Coldwell DM, Teng GJ (2012) A novel biliary stent loaded with I-125 seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol 56(5):1104-1111